Chisa Kondo

1.0k total citations
45 papers, 487 citations indexed

About

Chisa Kondo is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Chisa Kondo has authored 45 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 32 papers in Hepatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Chisa Kondo's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (13 papers). Chisa Kondo is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (13 papers). Chisa Kondo collaborates with scholars based in Japan, United States and South Korea. Chisa Kondo's co-authors include Masanori Atsukawa, Norio Itokawa, Akihito Tsubota, Katsuhiko Iwakiri, Tomomi Okubo, Taeang Arai, Noritomo Shimada, Katsuhisa Nakatsuka, Yūji Yoshida and Hiroshi Abe and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Chisa Kondo

43 papers receiving 482 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Chisa Kondo	336	289	82	69	69	45	487
Norio Itokawa	336 1.0×	290 1.0×	74 0.9×	82 1.2×	71 1.0×	54	519
Taeang Arai	276 0.8×	201 0.7×	63 0.8×	49 0.7×	94 1.4×	45	413
Tomomi Okubo	238 0.7×	190 0.7×	54 0.7×	46 0.7×	80 1.2×	39	364
Ian Homer Y.	473 1.4×	407 1.4×	40 0.5×	79 1.1×	99 1.4×	13	605
Yoshiko Kadokawa	366 1.1×	218 0.8×	85 1.0×	123 1.8×	138 2.0×	21	531
Kunitaka Fukuizumi	370 1.1×	258 0.9×	80 1.0×	77 1.1×	110 1.6×	37	512
Annette Dam Fialla	328 1.0×	259 0.9×	114 1.4×	63 0.9×	37 0.5×	21	467
S.G. Hübscher	327 1.0×	250 0.9×	95 1.2×	210 3.0×	93 1.3×	27	583
Hong‐Lei Ma	361 1.1×	152 0.5×	37 0.5×	79 1.1×	116 1.7×	27	459
Han Ah Lee	438 1.3×	360 1.2×	47 0.6×	55 0.8×	97 1.4×	46	563

Countries citing papers authored by Chisa Kondo

Since Specialization

Citations

This map shows the geographic impact of Chisa Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chisa Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chisa Kondo more than expected).

Fields of papers citing papers by Chisa Kondo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chisa Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chisa Kondo. The network helps show where Chisa Kondo may publish in the future.

Co-authorship network of co-authors of Chisa Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Chisa Kondo. A scholar is included among the top collaborators of Chisa Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chisa Kondo. Chisa Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okubo, Tomomi, Masanori Atsukawa, Akihito Tsubota, et al.. (2024). Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease. PLoS ONE. 19(3). e0299313–e0299313. 1 indexed citations

Atsukawa, Masanori, Akihito Tsubota, Yuichi Tamura, et al.. (2023). How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis. JGH Open. 7(8). 588–590. 2 indexed citations

Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2022). Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease. Scientific Reports. 12(1). 7311–7311. 2 indexed citations

Atsukawa, Masanori, Chisa Kondo, Tomomi Okubo, et al.. (2021). Development of interferon-free, direct-acting antivirals treatment for Japanese patients with chronic hepatitis C infection and chronic kidney disease. Journal of Nippon Medical School. 88(3). 163–170. 2 indexed citations

Arai, Taeang, Masanori Atsukawa, Akihito Tsubota, et al.. (2019). Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. PLoS ONE. 14(11). e0224184–e0224184. 12 indexed citations

Arai, Taeang, Masanori Atsukawa, Akihito Tsubota, et al.. (2019). Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Digestive and Liver Disease. 51(7). 1036–1042. 36 indexed citations

Atsukawa, Masanori, Katsuhisa Nakatsuka, Masumi Shimizu, et al.. (2018). Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression. PLoS ONE. 13(12). e0200664–e0200664. 9 indexed citations

Okubo, Tomomi, Masanori Atsukawa, Akihito Tsubota, et al.. (2018). Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment. Hepatology International. 12(2). 133–142. 16 indexed citations

Atsukawa, Masanori, Akihito Tsubota, Tomomi Okubo, et al.. (2017). Serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein more reliably distinguishes liver fibrosis stages in non‐alcoholic fatty liver disease than serum Mac‐2 binding protein. Hepatology Research. 48(6). 424–432. 14 indexed citations

10.

Atsukawa, Masanori, Akihito Tsubota, Chisa Kondo, et al.. (2017). Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C. Digestive and Liver Disease. 49(9). 1029–1035. 11 indexed citations

11.

Atsukawa, Masanori, Akihito Tsubota, Chisa Kondo, et al.. (2016). Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients. World Journal of Gastroenterology. 22(21). 5104–5104. 12 indexed citations

12.

Itokawa, Norio, Masanori Atsukawa, Akihito Tsubota, et al.. (2015). Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study. International Journal of Clinical Oncology. 21(4). 676–683. 4 indexed citations

13.

Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2015). Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients. BMC Infectious Diseases. 15(1). 344–344. 10 indexed citations

14.

Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2014). Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C. Digestive and Liver Disease. 46(8). 738–743. 14 indexed citations

15.

Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2014). Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C. European Journal of Gastroenterology & Hepatology. 26(7). 781–787. 3 indexed citations

16.

Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2014). Serum 25‐hydroxyvitamin D₃ levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load. Hepatology Research. 44(13). 1277–1285. 9 indexed citations

17.

Atsukawa, Masanori, Akihito Tsubota, Noritomo Shimada, et al.. (2013). Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepatitis Monthly. 13(12). e14872–e14872. 12 indexed citations

18.

Kondo, Chisa, Masanori Atsukawa, Akihito Tsubota, et al.. (2012). An open‐label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin. Journal of Viral Hepatitis. 19(9). 615–622. 25 indexed citations

19.

Matsushita, Yoko, Yoshiyuki Narahara, Shunji Fujimori, et al.. (2012). Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension. Journal of Gastroenterology. 48(5). 633–639. 12 indexed citations

20.

Itokawa, Norio, Masanori Atsukawa, Takayoshi Nishino, et al.. (2011). A case of IgG4-related disease with rectal cancer. Clinical Journal of Gastroenterology. 4(6). 374–380. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact